European Patent Office Grants PAR Key Respiratory Patent
Filed with ASX ·
6ix hasn’t read this filing yet.
Paradigm Biopharmaceuticals Ltd. on 6ix
Later from Paradigm Biopharmaceuticals
- Paradigm Biopharmaceuticals Receives Ethics Approval
- Paradigm Secures Key US Patent
- ASX Admission Market Release
- Shareholders Update
- Paradigm PPS nasal spray to treat Allergic Rhinitis
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals